AD

Arijit Das

Active Director Director DIN 00837829
DIN 00837829 First appointment Apr 2000 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 2 historical roles
Total affiliations 5 Since Apr 2000
Shareholding value •••• Premium profile

About Arijit Das

Data last updated:

Arijit Das is a Director at Ncd Immunomedicare Private Limited (since 2010), Director at Ncd Immuno-Pharma Private Limited (since 2022) and Whole-Time Director at Aerus Speciality Clinic & Diagnostics Private Limited (since 2022). The companies operate in Healthcare and Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹12.93 Cr; the largest is Ncd Immunomedicare Private Limited at ₹12.26 Cr (FY 2025). Earlier, Arijit Das was a Director at Lifespace Healthcare Private Limited (from 2009) and Director at Orion Immunogenics Private Limited (from 2000).

DIN 00837829
Primary Designation Director
Industry Healthcare
First Appointment 27 Apr 2000
Oldest Company Age 26 yrs
Largest company Ncd Immunomedicare Private Limited · ₹12.26 Cr (FY 2025)
Combined revenue ₹12.93 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ncd Immunomedicare Private Limited U33110WB2010PTC145296
Director16 Apr 20102010₹12.26 Cr (FY 2025)Active
Ncd Immuno-Pharma Private Limited U24231WB2022PTC252589
Director29 Mar 20222022₹66.7 Lakh (FY 2025)Active
Whole-Time Director29 Mar 20222022Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Lifespace Healthcare Private Limited U74900WB2009PTC135180
Director19 May 20092009Strike Off
Orion Immunogenics Private Limited U85194WB2000PTC091749
Director27 Apr 20002000Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Ncd Immuno-Pharma Private Limited
Ncd Immunomedicare Private Limited
Lifespace Healthcare Private Limited
Aerus Speciality Clinic & Diagnostics Private Limited
Premium access

Shareholding and investment profile for Arijit Das

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Arijit Das

Arijit Das currently holds 3 directorships: Ncd Immunomedicare Private Limited (Director, since 16 Apr 2010, revenue ₹12.26 Cr (FY 2025)); Ncd Immuno-Pharma Private Limited (Director, since 29 Mar 2022, revenue ₹66.7 Lakh (FY 2025)); Aerus Speciality Clinic & Diagnostics Private Limited (Whole-Time Director, since 29 Mar 2022).

Arijit Das was first appointed on 27 Apr 2000 as Director at Orion Immunogenics Private Limited. The most recent appointment on record is 29 Mar 2022 at Aerus Speciality Clinic & Diagnostics Private Limited.

The 2 current companies of Arijit Das that report revenue have a combined latest revenue of ₹12.93 Cr: Ncd Immunomedicare Private Limited ₹12.26 Cr (FY 2025); Ncd Immuno-Pharma Private Limited ₹66.7 Lakh (FY 2025).

Arijit Das held 2 earlier board appointments: Lifespace Healthcare Private Limited (Director, from 19 May 2009); Orion Immunogenics Private Limited (Director, from 27 Apr 2000).

The current boards of Arijit Das's companies include Arindam Das Barman (Ncd Immunomedicare Private Limited), Jayati Das (Ncd Immunomedicare Private Limited), Rishav Das (Ncd Immunomedicare Private Limited), Saibal Moitra (Ncd Immunomedicare Private Limited), Sandip Kumar Goswami (Ncd Immunomedicare Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available